Reports
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 |
Bromonidine eye drops | Specialist ophthalmologist recommendation |
|
|
Budesonide 2mg rectal foam (2mg per 1 metered dose) (Budenofalk®) | Approved to support the shortage of Colifoam (June 2018) |
|
|
Budesonide capsules (Budenofalk capsules 3mg) | Consultant initiation only |
|
|
Buprenorphine patches | Specialist initiation only. Patches must be prescribed by brand. |
|
|
Buprenorphine S/L tablets | ||
|
Cabergoline tablets | ||
|
Calcitriol | ||
|
Calcitriol ointment | ||
|
Calcium acetate with magnesium carbonate (OsvaRen) | ||
|
Calcium salts (Calcichew) |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
